BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 30392224)

  • 1. [Acquisition and the immunogenicity of the outer membrane FomA protein of
    Ma L; Feng XP; Wu QL; Zhang XY; Zhang X
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Oct; 53(10):674-680. PubMed ID: 30392224
    [No Abstract]   [Full Text] [Related]  

  • 2. The protective effect of recombinant FomA-expressing Lactobacillus acidophilus against periodontal infection.
    Ma L; Ding Q; Feng X; Li F
    Inflammation; 2013 Oct; 36(5):1160-70. PubMed ID: 23644821
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A preliminary study on the effect of histatin 5 inhibiting
    Wang HY; Liu JW; Li Q; Tan LS; Lin L; Pan YP
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Mar; 53(3):150-156. PubMed ID: 29972970
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical characterization of a recombinant Lactobacillus acidophilus strain expressing exogenous FomA protein.
    Ma L; Li F; Zhang X; Feng X
    Arch Oral Biol; 2018 Aug; 92():25-31. PubMed ID: 29747062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning of the fomA gene, encoding the major outer membrane porin of Fusobacterium nucleatum ATCC10953.
    Jensen HB; Skeidsvoll J; Fjellbirkeland A; Høgh B; Puntervoll P; Kleivdal H; Tommassen J
    Microb Pathog; 1996 Nov; 21(5):331-42. PubMed ID: 8938641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination targeting surface FomA of Fusobacterium nucleatum against bacterial co-aggregation: Implication for treatment of periodontal infection and halitosis.
    Liu PF; Shi W; Zhu W; Smith JW; Hsieh SL; Gallo RL; Huang CM
    Vaccine; 2010 Apr; 28(19):3496-505. PubMed ID: 20189489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-based adaptive immunity protect host from infection-associated periodontal bone resorption via recognition of Porphyromonas gingivalis virulence component.
    Han X; LaRosa KB; Kawai T; Taubman MA
    Vaccine; 2014 Jan; 32(2):297-303. PubMed ID: 24051159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Halitosis vaccines targeting FomA, a biofilm-bridging protein of fusobacteria nucleatum.
    Liu PF; Huang IF; Shu CW; Huang CM
    Curr Mol Med; 2013 Sep; 13(8):1358-67. PubMed ID: 23865430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Porphyromonas gingivalis outer membrane vesicles inhibit the invasion of Fusobacterium nucleatum into oral epithelial cells by downregulating FadA and FomA.
    Zhang Z; Liu S; Zhang S; Li Y; Shi X; Liu D; Pan Y
    J Periodontol; 2022 Apr; 93(4):515-525. PubMed ID: 34458990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cloning and expression of FomA, the major outer-membrane protein gene from Fusobacterium nucleatum T18.
    Haake SK; Wang X
    Arch Oral Biol; 1997 Jan; 42(1):19-24. PubMed ID: 9134112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusobacterium nucleatum envelope protein FomA is immunogenic and binds to the salivary statherin-derived peptide.
    Nakagaki H; Sekine S; Terao Y; Toe M; Tanaka M; Ito HO; Kawabata S; Shizukuishi S; Fujihashi K; Kataoka K
    Infect Immun; 2010 Mar; 78(3):1185-92. PubMed ID: 20008529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a 40-kDa outer membrane protein, FomA, of Fusobacterium periodonticum and comparison with Fusobacterium nucleatum.
    Bolstad AI; Høgh BT; Jensen HB
    Oral Microbiol Immunol; 1995 Oct; 10(5):257-64. PubMed ID: 8596666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The FomA porin from Fusobacterium nucleatum is a Toll-like receptor 2 agonist with immune adjuvant activity.
    Toussi DN; Liu X; Massari P
    Clin Vaccine Immunol; 2012 Jul; 19(7):1093-101. PubMed ID: 22623652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of interleukin-10 depletion in vivo on the immune response to Porphyromonas gingivalis in a murine model.
    Herminajeng E; Sosroseno W; Bird PS; Seymour GJ
    J Periodontol; 2001 Nov; 72(11):1527-34. PubMed ID: 11759864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abnormal pregnancy outcomes in mice using an induced periodontitis model and the haematogenous migration of Fusobacterium nucleatum sub-species to the murine placenta.
    Stockham S; Stamford JE; Roberts CT; Fitzsimmons TR; Marchant C; Bartold PM; Zilm PS
    PLoS One; 2015; 10(3):e0120050. PubMed ID: 25806806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein-lipid interactions with Fusobacterium nucleatum major outer membrane protein FomA: spin-label EPR and polarized infrared spectroscopy.
    Anbazhagan V; Vijay N; Kleinschmidt JH; Marsh D
    Biochemistry; 2008 Aug; 47(32):8414-23. PubMed ID: 18642853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of the antibody response by Porphyromonas gingivalis and Fusobacterium nucleatum in a mouse model.
    Gemmell E; Bird PS; Ford PJ; Ashman RB; Gosling P; Hu Y; Seymour GJ
    Oral Microbiol Immunol; 2004 Aug; 19(4):247-51. PubMed ID: 15209995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between gingivitis and the serum antibodies to the microbiota associated with periodontal disease in children with Down's syndrome.
    Morinushi T; Lopatin DE; Van Poperin N
    J Periodontol; 1997 Jul; 68(7):626-31. PubMed ID: 9249633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porphyromonas gingivalis Capsule-Mediated Coaggregation as a Virulence Factor in Mixed Infection With Fusobacterium nucleatum.
    Polak D; Ferdman O; Houri-Haddad Y
    J Periodontol; 2017 May; 88(5):502-510. PubMed ID: 27885964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response.
    Polak D; Wilensky A; Shapira L; Halabi A; Goldstein D; Weiss EI; Houri-Haddad Y
    J Clin Periodontol; 2009 May; 36(5):406-10. PubMed ID: 19419440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.